Discovery Underlying Porosome Therapeutics, Inc. Continues to Receive Global Recognition

Read More  

A Patient-Centric Approach Built On The Porosome

Read More  

Cystic Fibrosis Rescued by Reprogramming the Cell’s Secretory Machinery

Read More  

Joe Golemme, CFO of Porosome Therapeutics, Inc., invited to participate in the J.P. Morgan 42nd Annual Healthcare Conference 2024 (January 8-11th, 2024) in San Francisco, CA, USA.

Read More  

Porosome Therapeutic Inc.’s, first therapeutic approach for cystic fibrosis, has just been published as a preprint

Read More  

Porosome Therapeutics Announces Groundbreaking Approach to Advance Diabetes Treatment

Read More  

Editorial on the pioneering discovery of the porosome nearly 30-years ago and its current application in the development of novel therapeutics for the treatment and cure of a wide range of debilitating diseases, is published in the Discoveries Journal

Read More  

Porosome Therapeutics, Inc., Chairman, Prof. Dr. Bhanu P. Jena and Chairman of the Scientific Advisory Board, Prof. Dr. Joachim Frank have been invited to participate at the Nobel Prize Dialogue being held in Seoul, South Korea on September 24th 2023.

Read More  

Porosome Therapeutics, Inc. Files Comprehensive Patent for New Generation of Treatments for Cystic Fibrosis and Other Diseases

Read More  

Porosome Therapeutics is the new name of Viron.

Read More  

Endowed lectureship created at Wayne State University in the Department of Physiology, to recognize the pioneering scientific contributions of Prof. Bhanu P. Jena, Ph.D.

Read More  

Prof. Joachim Frank is the new Chairman of the Scientific Advisory Board!

Professor Joachim Frank is a 2017 Nobel Laureate in Chemistry

Read More